Sci. STKE, 16 April 2002
Immunology Going Against the Flow
The mechanism of action of a drug already used for immunosuppression reveals a new level of regulation of lymphocyte. Mandala et al. show that the active form of the drug FTY720 becomes phosphorylated once administered and resembles sphingosine-1-phosphate, a lipid whose activation of cognate receptors has been implicated in modulating the immune response. The drug and lipid achieve immunosuppressive effects by inhibiting the circulation of lymphocytes in the body.
S. Mandala, R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J. Milligan, R. Thornton, G.-J. Shei, D. Card, C. A. Keohane, M. Rosenbach, J. Hale, C. L. Lynch, K. Rupprecht, W. Parsons, H. Rosen, Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296, 346-349 (2002). [Abstract] [Full Text]
Citation: Going Against the Flow. Sci. STKE 2002, tw144 (2002).
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882